Machine learning predicts metastatic progression using novel differentially expressed lncRNAs as potential markers in pancreatic cancer
View ORCID ProfileHasan Alsharoh
doi: https://doi.org/10.1101/2023.11.01.23297724
Hasan Alsharoh
1“Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
Article usage
Posted November 03, 2023.
Machine learning predicts metastatic progression using novel differentially expressed lncRNAs as potential markers in pancreatic cancer
Hasan Alsharoh
medRxiv 2023.11.01.23297724; doi: https://doi.org/10.1101/2023.11.01.23297724
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2826)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12527)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4407)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2836)
- Health Policy (1044)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4161)
- Nursing (220)
- Nutrition (615)
- Oncology (2191)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (264)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6744)
- Radiology and Imaging (1483)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (362)
- Surgery (471)
- Toxicology (57)
- Transplantation (198)
- Urology (173)